EE03874B1 - (R)-3-N,N-ditsüklobutüülamino-8-fluoro-3,4-dihüdro-2H-1-bensopüraan-5-karboksam iidvesinik- tartraat, selle valmistamise meetod ja seda sisaldav ravimkoostis - Google Patents

(R)-3-N,N-ditsüklobutüülamino-8-fluoro-3,4-dihüdro-2H-1-bensopüraan-5-karboksam iidvesinik- tartraat, selle valmistamise meetod ja seda sisaldav ravimkoostis

Info

Publication number: EE03874B1
Authority: EE; Estonia
Prior art keywords: dicyclobutylamino; benzopyran; dihydro; fluoro; preparation
Prior art date: 1997-05-30

Application number

EEP199900549A

Other languages

English (en)

Estonian (et)

Inventor

Nyqvist H�kan

D. Sohn Daniel

Original Assignee

Astra Aktiebolag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-30

Filing date

1998-05-15

Publication date

2002-10-15

1998-05-15 Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag

2000-06-15 Publication of EE9900549A publication Critical patent/EE9900549A/xx

2002-10-15 Publication of EE03874B1 publication Critical patent/EE03874B1/xx

Links

OWQRJIMXYPCDLO-UHFFFAOYSA-N n',n'-di(cyclobutyl)-8-fluoro-3,4-dihydro-2h-chromene-5-carbohydrazide;2,3-dihydroxybutanedioic acid Chemical compound OC(=O)C(O)C(O)C(O)=O.C1=2CCCOC=2C(F)=CC=C1C(=O)NN(C1CCC1)C1CCC1 OWQRJIMXYPCDLO-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)

EEP199900549A 1997-05-30 1998-05-15 (R)-3-N,N-ditsüklobutüülamino-8-fluoro-3,4-dihüdro-2H-1-bensopüraan-5-karboksam iidvesinik- tartraat, selle valmistamise meetod ja seda sisaldav ravimkoostis EE03874B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9702066A SE510305C2 (sv)	1997-05-30	1997-05-30	Nytt salt
PCT/SE1998/000907 WO1998054166A1 (en)	1997-05-30	1998-05-15	A new salt

Publications (2)

Publication Number	Publication Date
EE9900549A EE9900549A (et)	2000-06-15
EE03874B1 true EE03874B1 (et)	2002-10-15

Family

ID=20407187

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP199900549A EE03874B1 (et)	1997-05-30	1998-05-15	(R)-3-N,N-ditsüklobutüülamino-8-fluoro-3,4-dihüdro-2H-1-bensopüraan-5-karboksam iidvesinik- tartraat, selle valmistamise meetod ja seda sisaldav ravimkoostis

Country Status (33)

Country	Link
US (2)	US6858645B2 (id)
EP (1)	EP0984952B1 (id)
JP (1)	JP3554338B2 (id)
KR (1)	KR20010013127A (id)
CN (1)	CN1198814C (id)
AR (1)	AR012751A1 (id)
AT (1)	ATE228121T1 (id)
AU (1)	AU729301B2 (id)
BG (1)	BG64051B1 (id)
BR (1)	BR9809519A (id)
CA (1)	CA2291732C (id)
DE (1)	DE69809547T2 (id)
DK (1)	DK0984952T3 (id)
EE (1)	EE03874B1 (id)
ES (1)	ES2187030T3 (id)
HU (1)	HUP0001878A3 (id)
ID (1)	ID23794A (id)
IL (1)	IL133234A (id)
IS (1)	IS1943B (id)
MY (1)	MY117960A (id)
NO (1)	NO995853L (id)
NZ (1)	NZ501075A (id)
PL (1)	PL337181A1 (id)
PT (1)	PT984952E (id)
RU (1)	RU2193560C2 (id)
SE (1)	SE510305C2 (id)
SK (1)	SK282755B6 (id)
TR (1)	TR199902926T2 (id)
TW (1)	TW510899B (id)
UA (1)	UA53720C2 (id)
WO (1)	WO1998054166A1 (id)
YU (1)	YU62499A (id)
ZA (1)	ZA984486B (id)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0102888D0 (sv) *	2001-08-29	2001-08-29	Astrazeneca Ab	New formulation
SE0102886D0 (sv) *	2001-08-29	2001-08-29	Astrazeneca Ab	New formulation
SE0102887D0 (sv) *	2001-08-29	2001-08-29	Astrazeneca Ab	New formulation
AU2003256430A1 (en) *	2002-08-15	2004-03-03	Wyeth	AGONISM OF THE 5HT2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION
SE0301795D0 (sv) *	2003-06-19	2003-06-19	Astrazeneca Ab	New use I
SE0301796D0 (sv) *	2003-06-19	2003-06-19	Astrazeneca Ab	New use II
EP2022110B1 (en) *	2006-05-11	2011-10-12	Johnson Controls Saft Advanced Power Solutions LLC	Modular battery system
JP5163931B2 (ja) *	2007-03-08	2013-03-13	株式会社リコー	定着装置及び画像形成装置
EP2065385A1 (en) *	2007-11-28	2009-06-03	Laboratorios SALVAT, S.A.	Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
CN103833712B (zh) *	2008-11-28	2016-02-03	中国医学科学院药物研究所	硝克柳胺化合物晶ii型、其制法和其药物组合物与用途
WO2014174102A1 (en) *	2013-04-26	2014-10-30	Sanofi	Tartrate salt of 5-chloro-thiophene-2-carboxylic acid [(s)-2-[methyl-3-(2-oxo-pyrrolidin-1-yl)-benzenesulfonylamino]-3-(4-methyl piperazin-1 -yl)-3-oxo-propryl]amide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE62231B1 (en) *	1987-12-24	1995-01-11	Wyeth John & Brother Ltd	Heterocyclic compounds
US5616610A (en)	1989-12-22	1997-04-01	Astra Aktiebolag	(R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
US5420151A (en) *	1989-12-22	1995-05-30	Aktiebolaget Astra	Chroman derivatives
RU2047614C1 (ru) *	1992-06-15	1995-11-10	Джон Вайс энд Бразер Лимитед	Гетероциклические соединения, или их фармацевтически приемлемые аддитивные соли кислоты, или n-оксид гетероциклического соединения, или его аддитивная соль кислоты
IT1282705B1 (it)	1996-02-28	1998-03-31	Recordati Chem Pharm	Uso di antagonisti del recettore serotoninergico 5-ht\|a per il trattamento dell'incontinenza urinaria
US5990114A (en)	1996-02-28	1999-11-23	Recordati, S.A., Chemical And Pharmaceutical Company	Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence

1997
- 1997-05-30 SE SE9702066A patent/SE510305C2/sv not_active IP Right Cessation
1998
- 1998-05-13 TW TW087107397A patent/TW510899B/zh active
- 1998-05-15 HU HU0001878A patent/HUP0001878A3/hu unknown
- 1998-05-15 RU RU99128026/04A patent/RU2193560C2/ru not_active IP Right Cessation
- 1998-05-15 PL PL98337181A patent/PL337181A1/xx unknown
- 1998-05-15 DK DK98925993T patent/DK0984952T3/da active
- 1998-05-15 EE EEP199900549A patent/EE03874B1/xx not_active IP Right Cessation
- 1998-05-15 KR KR19997011107A patent/KR20010013127A/ko not_active Abandoned
- 1998-05-15 ID IDW991407A patent/ID23794A/id unknown
- 1998-05-15 NZ NZ501075A patent/NZ501075A/en unknown
- 1998-05-15 US US09/077,718 patent/US6858645B2/en not_active Expired - Fee Related
- 1998-05-15 CN CNB988056631A patent/CN1198814C/zh not_active Expired - Fee Related
- 1998-05-15 PT PT98925993T patent/PT984952E/pt unknown
- 1998-05-15 AT AT98925993T patent/ATE228121T1/de not_active IP Right Cessation
- 1998-05-15 CA CA002291732A patent/CA2291732C/en not_active Expired - Fee Related
- 1998-05-15 TR TR1999/02926T patent/TR199902926T2/xx unknown
- 1998-05-15 YU YU62499A patent/YU62499A/sh unknown
- 1998-05-15 DE DE69809547T patent/DE69809547T2/de not_active Expired - Fee Related
- 1998-05-15 UA UA99127241A patent/UA53720C2/uk unknown
- 1998-05-15 WO PCT/SE1998/000907 patent/WO1998054166A1/en not_active Ceased
- 1998-05-15 EP EP98925993A patent/EP0984952B1/en not_active Expired - Lifetime
- 1998-05-15 SK SK1594-99A patent/SK282755B6/sk unknown
- 1998-05-15 JP JP50056099A patent/JP3554338B2/ja not_active Expired - Fee Related
- 1998-05-15 IL IL13323498A patent/IL133234A/en not_active IP Right Cessation
- 1998-05-15 BR BR9809519-6A patent/BR9809519A/pt not_active IP Right Cessation
- 1998-05-15 ES ES98925993T patent/ES2187030T3/es not_active Expired - Lifetime
- 1998-05-15 AU AU77923/98A patent/AU729301B2/en not_active Ceased
- 1998-05-26 AR ARP980102434A patent/AR012751A1/es unknown
- 1998-05-26 ZA ZA984486A patent/ZA984486B/xx unknown
- 1998-05-29 MY MYPI98002400A patent/MY117960A/en unknown
1999
- 1999-11-24 IS IS5270A patent/IS1943B/is unknown
- 1999-11-29 NO NO995853A patent/NO995853L/no not_active Application Discontinuation
- 1999-12-03 BG BG103949A patent/BG64051B1/bg unknown
2004
- 2004-10-12 US US10/964,388 patent/US20050085532A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HUP0001878A2 (hu)	2001-05-28
DE69809547D1 (de)	2003-01-02
WO1998054166A1 (en)	1998-12-03
ID23794A (id)	2000-05-11
HK1025575A1 (en)	2000-11-17
CA2291732C (en)	2003-12-30
BR9809519A (pt)	2000-06-20
AU729301B2 (en)	2001-02-01
SE9702066L (sv)	1998-12-01
ES2187030T3 (es)	2003-05-16
EE9900549A (et)	2000-06-15
CA2291732A1 (en)	1998-12-03
AR012751A1 (es)	2000-11-08
YU62499A (sh)	2002-06-19
SK282755B6 (sk)	2002-12-03
MY117960A (en)	2004-08-30
CN1198814C (zh)	2005-04-27
EP0984952B1 (en)	2002-11-20
CN1258290A (zh)	2000-06-28
US20030109576A1 (en)	2003-06-12
JP3554338B2 (ja)	2004-08-18
IS5270A (is)	1999-11-24
US6858645B2 (en)	2005-02-22
DK0984952T3 (da)	2003-02-24
UA53720C2 (uk)	2003-02-17
EP0984952A1 (en)	2000-03-15
PL337181A1 (en)	2000-08-14
NZ501075A (en)	2001-08-31
US20050085532A1 (en)	2005-04-21
SE510305C2 (sv)	1999-05-10
BG64051B1 (bg)	2003-11-28
PT984952E (pt)	2003-03-31
RU2193560C2 (ru)	2002-11-27
IL133234A0 (en)	2001-03-19
DE69809547T2 (de)	2003-08-21
JP2002501527A (ja)	2002-01-15
BG103949A (en)	2000-07-31
NO995853D0 (no)	1999-11-29
IS1943B (is)	2004-08-13
AU7792398A (en)	1998-12-30
KR20010013127A (ko)	2001-02-26
HUP0001878A3 (en)	2002-04-29
SK159499A3 (en)	2000-10-09
TW510899B (en)	2002-11-21
SE9702066D0 (sv)	1997-05-30
NO995853L (no)	2000-01-31
ATE228121T1 (de)	2002-12-15
TR199902926T2 (xx)	2000-03-21
ZA984486B (en)	1998-11-30
IL133234A (en)	2004-05-12

Similar Documents

Publication	Publication Date	Title
EE05214B1 (et)	2009-10-15	Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
ZA9811759B (en)	1999-07-28	Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them.
IL135920A0 (en)	2001-05-20	2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
HUP0004024A3 (en)	2001-10-29	Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
HUP0003844A3 (en)	2002-11-28	Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them
HUP0001539A3 (en)	2003-01-28	2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
HUP9802422A3 (en)	2002-02-28	Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them
HUP0203902A3 (en)	2003-07-28	Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
HUP0000721A3 (en)	2002-12-28	Gemcitabine derivatives, process for their preparation and pharmaceutical compositions containing them
EE03613B1 (et)	2002-02-15	Omeprasooli naatriumisool,selle valmistamise protsess,seda sisaldav ravimkoostis ja selle kasutamine seedetrakti häirete ravimiseks
IL140084A0 (en)	2002-02-10	Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0102475A3 (en)	2001-12-28	Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same
EE03338B1 (et)	2001-02-15	Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
HUP0001508A3 (en)	2003-01-28	4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP0103404A3 (en)	2002-08-28	Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0102334A3 (en)	2003-12-29	Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing the compound
HUP0102512A3 (en)	2002-08-28	Bridged indenopyrrolocarbazoles, process for their preparation, pharmaceutical compositions containing them and their use
EE200000596A (et)	2002-06-17	Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
IL139529A0 (en)	2001-11-25	Platinum complexes, processes for the preparation thereof and pharmaceutical compositions containing the same
IL137494A0 (en)	2001-07-24	Polypeptide compounds, process for the preparation thereof and pharmaceutical compositions containing the same
HU9800781D0 (en)	1998-05-28	Propanolamine derivatives, process for producing them, pharmaceutical compositions containing them and their use
EE03874B1 (et)	2002-10-15	(R)-3-N,N-ditsüklobutüülamino-8-fluoro-3,4-dihüdro-2H-1-bensopüraan-5-karboksam iidvesinik- tartraat, selle valmistamise meetod ja seda sisaldav ravimkoostis
EE200200199A (et)	2003-06-16	N-guanidinoalküülamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
HUP0001093A3 (en)	2001-07-30	Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
HRP20000479A8 (hr)	2025-09-12	Novi pentasaharidi, postupci njihove priprave i farmaceutske mješavine koje ih sadržavaju

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20060515